James Dondero is the founder and the president of the Highland capital management. He has a vast experience in the credit and equity markets. The company is focused on getting high yields. Some of the services and products that Highlands’s offers include separate institutional accounts, private equity funds, REITs, mutual funds hedge funds and CLOs. Under the leadership of Mr. Dondero, the company has grown in developing the (CLO) collateralized loan obligation market and advancing credit-oriented solutions for local and international investors. The company was founded in 1993, and its headquarters are in Dallas, Texas. It is one of the largest credit managers in the USA.
James Dondero was accepted into the Morgan Guaranty training program in 1984; this marked the beginning of his career journey as a financial analyst. In 1985, James graduated from the University of Virginias McIntyre School of commerce with a degree in accounting and finance. James is a certified management accountant. After his graduation, he joined the American Express as a corporate Bond analysts and later on became the manager of the company. He also works as a board of directors at the MGM studios and American banknote and the chairman of the board of directors of Nexbank, cornerstone health care and CCS Medical Corporation.
James is a charitable man who is dedicated to improving the lives of people living in Dallas Texas. James and his company donated funds to a zoo, in Dallas called the Perot museum of natural.He has also donated funds to improve institutions like the George w bush presidential library institute. James Dondero participated in programs like: “Education freedom” In assisting to uplift education in Dallas and the snowball express. James and Mary Jalonick, the founder of the Dallas Foundation, joined forces to form Highlands Dallas foundation that focuses on supporting veterans, health needs and educational needs in North Texas. Highlands’s capital management hosted a mother’s day event at the Dallas zoo, to raise additional funds for the residents. In June 2016, James Dondero merged with Linda Owen a civic leader and the former president of the Woodall Rodgers park foundation to assist in providing excellent leaderships charitable giving programs. James donates 3 million dollars yearly to charity.
More information on James Dondero can be found by following him on Twitter.
Mark McKenna is a father who takes time for his child even when the busyness of life threatens his hours. He is not about to let his daughter get pushed aside as he lives out his life and works as a doctor. Dr. Mark McKenna is a husband who is there for his wife even as he focuses on his career. When he was interviewed and asked what a typical day looks like for him, Mark McKenna mentioned that he has breakfast with his little girl each day. He spends time with his daughter and gives his wife the chance to get a little extra sleep.
When he was asked about something that he does that has led to his success, Mark McKenna mentioned that he reads a lot. When he was asked to give an example of a trend that has excited him recently, he mentioned that the decline in smoking in America is something that he sees as a good thing. Mark McKenna is someone who has spent time working for himself since he was young, and he mentioned that he has never really had a job because of that fact. When he was asked if he would do anything differently if he were to begin his career again, he mentioned that he would try to find his passion when he was younger.
Dr. Mark McKenna is a medical doctor who is licensed to practice in both Georgia and Florida. He is someone who knows what he is doing, and he has had a great career because of the way in which he works. Before starting his career, he graduated from the Tulane University Medical School.
Mark McKenna is a member of the Entrepreneurs Organization and he has spent time serving as a board member for the New Orleans Jazz Festival in the past. He is a man who lives a busy life because of his job, but who also takes the time for his family and for other ventures.
Home décor magazines are quite popular in New York. Considered one of the most beautiful cities in the world, people are eager to brighten up their living spaces with ideas from New York’s best interior designers. A name that has featured numerous times in such magazines is Richard Mishaan. The founder and manager of Richard Mishaan Design is considered interior design royalty in New York, and for a good reason.
Brought up in Colombia, Richard Mishaan moved to the United States in his adulthood and studied at the University of New York. He began his career working for the famed architect, Phillip Johnson. The brief experience with Mr. Johnson laid sparked his interest in design and led him on a path to become one of the most skilled and unique in New York’s interior design industry. As opposed to holding him back, his educational background in architecture gave him an edge over his peers by enabling him to see perspectives others did not. Soon after graduating with his postgraduate degree, Mishaan decided that it was time he created his artistic designs. Therefore, about two-and-a-half decades ago, he founded the firm, Richard Mishaan Design
Richard Mishaan is what many would call an interior design purist. He does not believe in boundaries when working on his projects. Consequently, a look through Richard Mishaan Design’s portfolio reveals spaces that combine modernity and antiquity in a peculiar but aesthetic and functional manner. His secret life is that he draws much of the inspiration for these designs from his own experiences. Growing up in Colombia exposed him to color and historical art. Equally, his move to New York exposed him to symmetry and modern art. Consequently, the designs he creates are merely representations of the various experiences he has had in life. Since these experiences cannot be bought or copied, Richard Mishaan Design has consistently remained at the top for the last 26 years.
Of all the different types of cancer, prostate cancer is the most common among men. Cancer Treatment Centers of America®, Labcorp®, and National Football League Alumni Association are collaborating to educate people and increase access to screenings as a way of creating more awareness. LabCorp has been giving men aged 40 and above chance for free Prostate Specific Antigen screening as from September 1st all the way to October 15th. This platform is available for those who meet the eligibility requirements and sign up afterward. It is mandatory for the screening to be taken within six months of the sign-up date.
People Prone to Getting Prostate Cancer
The health experts state that individuals who got a family history of prostate cancer and those with African- American race suffer a high likelihood of getting prostate cancer. Experts, therefore, recommend that those who are viewed as the high risk to get screened at the beginning of age forty. There being one out of seven males with prostate cancer, the American Cancer Society states there will be an addition of 161,360 new cases of prostate cancer in 2017.
Sean Cavanaugh, managing director of Cancer Treatment Centers of America, states that screening is the first step against prostate cancer. He further indicates that it’s their pleasure at CTCA to work with LabCorp and NFLA in raising the awareness on the vitality of screening.
An Overview of Cancer Treatment Centers of America
CTCA® is a national setup of five hospitals that are devoted helping adults who are fighting cancer. The company has its headquarters at Boca Raton, Fla. It helps patients from around the world at its branches in Phoenix, Atlanta, Chicago, Tulsa, and Philadelphia. CTCA offers a diversified approach that combines advancement in precision cancer treatment, chemotherapy, radiation, surgery, genomic testing, and immunotherapy. The services at CTCA ensure that they help the patients both emotionally and physically while managing side effects during and after treatment.
Follow Cancer Treatment Centers of America on LinkedIn, here.
Mikhail Blagosklonny, a leading oncology and anti-aging researcher, explained the health benefits of Rapamycin, including its anti-aging properties. He confirms that Rapamycin is the medicine of future, and further research on its benefits can bring more incredible results. It was isolated from a bacterium named Sirolimus in 1972 and initially, used as an anti-fungal agent. Later, it was also started using as a drug to treat the organ transplant rejection found in the humans. In the later years, Mikhail Blagosklonny started researching on the benefits of the drug and found that it can produce wonders in the human body with many healthcare benefits.Blagosklonny identified that Rapamycin could be administered effectively to increase the lifespan in human beings. He says that it can be used to treat people struggling with hemolytic-uremic syndrome – a rare disease that includes kidney failure, low platelet count, and anemia. In such health conditions, kidney transplantation is the only solution, and Rapamycin would ensure smooth acceptance of the external organ into the human body. Additionally, it also showcases lower rate of toxicity towards kidneys.
It is also an effective drug in treating Lymphangioleiomyomatosis – a rare lung disease that is observed in women while they are pregnant. The drug is also identified as an option of cancer treatment for Facial angiofibromas, and Rapamycin is found to be producing better results than laser treatment option. Rapamycin is also effective in the coating of coronary stents. The coating is to prevent the possibilities of re-stenosis in the arteries due to balloon angioplasty. Blagosklonny also says that the drug is effective in cancer treatment as its antiproliferative properties play a major role in increasing immunity. It is proved that when taken in the right dose, the drug has the ability to increase the immune response towards cancerous cells. Additionally, it also promotes tumor regression and works as a preventive option to reduce the risk of cancer. It is also identified that the drug can be used for the treatment of Tuberous Sclerosis Complex, a congenital disorder which can cause tumor growth in kidneys, heart, brain, and other organs.
Blagosklonny further says that it can also provide significant results in Alzheimer’s disease and Muscular Dystrophy.Mikhail Blagosklonny is also a great philanthropist and professor with a vision of developing efficient treatment solutions that are accessible by anyone, irrespective of the financial conditions. He is considered as a towering figure in both anti-aging research and oncology, and researchers around the world demand his guidance in both the areas. Through cancer research, Blagosklonny is looking for a cancer treatment option that can ensure killing of cancerous cells without damaging the healthy cells of the human body – an important factor in deciding the recovery of the patient.Blagosklonny has made significant progress in both anti-aging research and cancer treatment in the recent years. He has published over 300 research papers, notes, reviews, and more. Blagosklonny has collaborated with a number of science and medical journals and worked on their editorial boards in different roles. Currently, he is working as a researcher at Rosewell Park Cancer Institute.